$ARIA Headlines Six stocks to watch 4:27 p.m. Feb. 26,

New Post Public Reply Private Reply Replies (0) Message Board

Jul 9, 2014 at 12:22 PM

$ARIA Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com

ARIAD Pharmaceuticals (ARIA) Is Water-Logged And Getting Wetter Today 10:39 a.m. July 8, 2014 - TheStreet.com
UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog 6:10 p.m. July 7, 2014 - Zacks.com
OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog 4:30 p.m. July 7, 2014 - Zacks.com
Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock - Tale of the Tape 8:42 a.m. July 7, 2014 - Zacks.com
Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape 9:46 a.m. July 3, 2014 - Zacks.com
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 8:51 a.m. July 3, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape 9:46 a.m. July 2, 2014 - Zacks.com
Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% - Tale of the Tape 8:59 a.m. July 2, 2014 - Zacks.com
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape 8:51 a.m. July 2, 2014 - Zacks.com
IGI Laboratories (IG) Worth Watching: Stock Rises 6.2% - Tale of the Tape 9:25 a.m. July 1, 2014 - Zacks.com
Auxilium Pharmaceuticals (AUXL) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:59 a.m. July 1, 2014 - Zacks.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. June 30, 2014 - Zacks.com
Pacira's Exparel Positive in Phase IV Studies - Analyst Blog 11:30 a.m. June 27, 2014 - Zacks.com
QLT Inc. (QLTI) in Focus: Stock Surges 14.63% - Tale of the Tape 8:44 a.m. June 27, 2014 - Zacks.com
Heron Therapeutics (HRTX) in Focus: Stock Falls 8.9% in Session - Tale of the Tape 8:51 a.m. June 26, 2014 - Zacks.com
Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog 5:20 p.m. June 24, 2014 - Zacks.com
Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape 9:18 a.m. June 24, 2014 - Zacks.com
Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape 8:35 a.m. June 24, 2014 - Zacks.com
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape 9:46 a.m. June 23, 2014 - Zacks.com

Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:01 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:36 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:16 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:36 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:36 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:36 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated "Outperform" by RW Baird 1:01 a.m. April 8, 2014 - ACCESSWIRE
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE 12:13 a.m. April 3, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brigham Nurses Set to Strike: MGB Board Faces Scrutiny

Pressure Cooker: MGB in the Hot Seat Nurses from Brigham and Women's Hospital aren't backing down, folks. They're feverishly preparing for a full-scale strike, set to kick off on November 12, if Mass General Brigham (MGB) doesn't budge on contract negotiations. Since today is November 6, they've got just a few days to find common ground. Let me tell you, the stakes...

Soligenix Holds Steady Amidst Shifting Financial Landscape

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

BETR Investors Face Deadline in Class Action Case

Investor Deadline Looms for BETR Losses Ah, the tangled web of finance promises and posturing! Investors in Better Home & Finance Holding Company (NASDAQ: BETR) are now standing at a financial crossroads, thanks to an unfolding legal drama. You've got until November 20, 2026, to align your ducks and join a federal securities class action lawsuit, put forth by Hagens...

Used Truck Inventory Shrinks as Auction Values Rise

October's Tailspin in Used Truck Inventory If you've been around the block in the trucking industry, the latest from Sandhills Global might just knock your socks off. Their October rundown is out, and it's looking bleak for anyone trying to grab a used truck or trailer at a bargain. We're seeing a real crunch in inventory, and that’s an understatement. Navigating a...

Education Cannot Wait Nears US$600M Goal in Geneva

Global Support Bolsters Education Cannot Wait Just when you think the world’s going sideways, some stories give you a dash of hope. The recent pledges at the Geneva conference have pumped Education Cannot Wait (ECW) up to 90% of the US$600 million goal. That’s some progress in tight times. With US$405.8 million freshly announced, they’ve got US$541.6 million in the...

TEN Holdings' Q3: Cost Cuts Fuel Revenue Ambitions

TEN Holdings Eyes the Future While Cleaning House If there’s one thing that catches the eye about TEN Holdings' Q3 2026 results, it’s the laser-focused cleanup of their balance sheet. They’ve slashed liabilities by 74%, up from $7.7 million at the arse end of last year to just over $2 million now. They did that by making some hard moves, hacking away at operating...

Reliving the Legacy of Friendship at Friends & Co

Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...

Mount St. Mary’s University Secures Future for High Schoolers

Breaking Ground: Education Made Accessible Boy, oh boy, this move between Mount St. Mary’s University and Saint John Vianney High School is something that just warmed up my trading heart like a surprise market rally. They've inked a deal—a Memorandum of Understanding (MOU)—to fling open the doors to higher education for high schoolers who've got their eyes on the...

Lululemon Faces Class Action Amid Sales Decline

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Cavli's Latest Innovations Shine at electronica 2026

Cavli Wireless: Paving the Path for Smarter IoT There's a storm brewing in Munich at electronica 2026, and Cavli Wireless is the name spurred across tech-savvy lips. With their latest revelation—the P16QS LTE Cat 1bis module and Cortex AI—the firm’s tossing bold challenges at the IoT and AI landscape. It's a gutsy move, cementing their role as a frontier pusher in a...